Amedisys, Inc. (AMED) Misses Q1 EPS by 6c; Guides Well Below the Street

April 30, 2013 8:45 AM

Amedisys, Inc. (NASDAQ: AMED) reported Q1 EPS of $0.13, $0.06 worse than the analyst estimate of $0.19. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found